Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Karyotypic patterns in acute mixed lineage leukemia.

Y Hayashi1, K Sugita, S Nakazawa

  • 1Division of Hematology/Oncology, Saitama Children's Medical Center, Japan.

Leukemia
|February 1, 1990
PubMed
Summary

Cytogenetic analysis of acute mixed lineage leukemia (AMLL) in children reveals distinct patterns. Chromosome alterations like 11q23 translocations and t(9;22) correlate with specific antigen expressions, aiding in disease classification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary progressive apraxia in Pick's disease: a clinicopathologic study.

Neurology·1996
Same author

(2E)-5-[3-[(phenylsulfonyl)amino]phenyl]-pent-2-en-4-ynohydroxamic acid and its derivatives as novel and potent inhibitors of ras transformation.

Journal of medicinal chemistry·1996
Same author

Oxamflatin: a novel compound which reverses malignant phenotype to normal one via induction of JunD.

Oncogene·1996
Same author

[Two early-childhood cases of optic neuritis].

No to hattatsu = Brain and development·1996
Same author

Mechanisms of glucocorticoid resistance in human leukemic cells: implication of abnormal 90 and 70 kDa heat shock proteins.

Leukemia·1996
Same author

Simultaneous measurement of Ca2+ and pH by laser cytometry using fluo-3 and SNARF-1.

Cytometry·1996

Area of Science:

  • Pediatric Hematology/Oncology
  • Cancer Cytogenetics
  • Immunophenotyping

Background:

  • Acute mixed lineage leukemia (AMLL) presents a diagnostic challenge due to its mixed myeloid and lymphoid features.
  • Accurate classification of AMLL is crucial for determining appropriate treatment strategies and predicting patient outcomes.
  • Understanding the underlying genetic and immunophenotypic profiles can refine AMLL classification.

Purpose of the Study:

  • To investigate cytogenetic and immunologic characteristics of blast cells in pediatric AMLL.
  • To identify patterns of chromosome alterations and antigen expression that can aid in AMLL classification.
  • To correlate specific karyotypic abnormalities with distinct immunophenotypes in AMLL.

Main Methods:

  • Performed cytogenetic studies to analyze chromosome alterations in blast cells from 13 children with AMLL.

Related Experiment Videos

  • Conducted immunologic studies to assess antigen expression (e.g., CD19, HLA-DR, CD10, CD13) on blast cells.
  • Correlated cytogenetic findings with immunophenotypic data and clinical features (age, hyperleukocytosis).
  • Main Results:

    • Six patients with 11q23 translocations (including t(11;19), t(9;11), t(1;11)) were younger and had hyperleukocytosis; blasts expressed CD19 and HLA-DR, with only one case positive for CD10 (CALLA).
    • Four patients with t(9;22)(q34;q11) were older and had hyperleukocytosis; blasts expressed CD13, CD19, and HLA-DR, with three cases positive for CD10 (CALLA).
    • 11q23 translocations were associated with CD10-negative ALL with a myeloid phenotype, while t(9;22) occurred in CD10-positive AML with a lymphoid phenotype. One case showed a 7q35-q36 translocation.

    Conclusions:

    • Karyotypic alterations, specifically 11q23 translocations and t(9;22), are associated with distinct immunophenotypes in pediatric AMLL.
    • The findings suggest that cytogenetic analysis can refine the classification of AMLL, differentiating between lymphoid and myeloid phenotypes.
    • These correlations provide valuable insights for improved diagnostic and therapeutic approaches in pediatric AMLL.